Skip to main content
Pharmaceutical product and formulation background
Pharmaceutical Division

Dronabinol

Dronabinol is used to treat nausea and vomiting caused by chemotherapy and to treat anorexia.

Under developmentTreat nausea and vomiting caused by chemotherapy and AnorexiaCAS 1972-08-3
✓Quality Assured
✓Cannabinoid
✓Under development

Detailed technical, regulatory, and supply information is available for commercial evaluation.

Technical Overview

Dronabinol – CAS 1972-08-3

Under development

CAS Number

1972-08-3

Category

Treat nausea and vomiting caused by chemotherapy and Anorexia

Therapeutic Class

Cannabinoid

Description

Dronabinol is used to treat nausea and vomiting caused by chemotherapy and to treat anorexia.

Applications

  • Chemotherapy-induced nausea
  • Anorexia treatment
  • Appetite stimulant

Handling & Supply Details

Packaging

Standard export packaging in double-lined HDPE drums or fiber drums with inner poly liners; custom pack sizes available on request.

Product Inquiry

Disclaimer

Products offered are intended strictly for R&D, registration and/or export purposes only. The responsibility for ensuring that the product does not infringe any third-party patent or intellectual property rights in the destination country rests solely with the buyer.

This website uses cookies to optimize your navigation and adapt to your preferences. You can continue browsing without accepting. If you select "Accept", you accept the use of ALL cookies. You can also select cookies in "Cookie settings" and consult our Cookies Policy and Privacy Policy here.